APO Research

APO RESEARCH · REPORT

Hemostat Powder

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Product & engineering

Understand the product.

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Hemostat powder is product in form of powder.

Selected research

Industry Growth & Trends

Global Hemostat Powder Industry Growth and Trends Forecast to 2032

Market perspective

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.

Hemostat powder is product in form of powder.

Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.

The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.

Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.

Report Scope

This report provides a structured, data-driven view of the global Hemostat Powder market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemostat Powder market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostat Powder market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostat Powder.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemostat Powder market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemostat Powder Market by Company

Johnson & Johnson

C. R. Bard

Pfizer

CSL Behring

Gelita Medical

Ferrosan Medical Devices

Baxter

Celox

Equimedical

Medira

Biocer

Hemostasis

MBP

Hemostat Powder Segment by Type

Gelatin

Fibrin

Cellulose

Others

Hemostat Powder Segment by Application

Surgical Wound Care

General Wound Care

Hemostat Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostat Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostat Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostat Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemostat Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gelatin Table 2. Major Company of Fibrin Table 3. Major Company of Cellulose Table 4. Major Company of Others Table 5. Global Hemostat Powder Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 7. Global Hemostat Powder Sales Market Share in Volume by Type (2021-2026) Table 8. Global Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 9. Global Hemostat Powder Sales Market Share in Value by Type (2021-2026) Table 10. Global Hemostat Powder Price by Type (2021-2026) & (USD/Unit) Table 11. Global Hemostat Powder Sales by Type (2027-2032) & (K Units) Table 12. Global Hemostat Powder Sales Market Share in Volume by Type (2027-2032) Table 13. Global Hemostat Powder Sales by Type (2027-2032) & (US$ Million) Table 14. Global Hemostat Powder Sales Market Share in Value by Type (2027-2032) Table 15. Global Hemostat Powder Price by Type (2027-2032) & (USD/Unit) Table 16. North America Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 17. North America Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 19. Europe Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 23. Latin America Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Hemostat Powder Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Hemostat Powder Sales by Type (2021-2026) & (US$ Million) Table 26. Hemostat Powder Industry Trends Table 27. Hemostat Powder Industry Drivers Table 28. Hemostat Powder Industry Opportunities and Challenges Table 29. Hemostat Powder Industry Restraints Table 30. Global Hemostat Powder Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Hemostat Powder Revenue Market Share by Company (2021-2026) Table 32. Global Hemostat Powder Sales by Company (2021-2026) & (K Units) Table 33. Global Hemostat Powder Sales Share by Company (2021-2026) Table 34. Global Hemostat Powder Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Hemostat Powder Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Hemostat Powder Major Company Production Sites and Headquarters Table 37. Global Hemostat Powder Company, Product Type & Application Table 38. Global Hemostat Powder Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Hemostat Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Hemostat Powder Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Hemostat Powder Sales by Region (2021-2026) & (K Units) Table 43. Global Hemostat Powder Sales Market Share in Volume by Region (2021-2026) Table 44. Global Hemostat Powder Sales by Region (2021-2026) & (US$ Million) Table 45. Global Hemostat Powder Sales Market Share in Value by Region (2021-2026) Table 46. Global Hemostat Powder Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Hemostat Powder Sales by Region (2027-2032) & (K Units) Table 48. Global Hemostat Powder Sales Market Share in Volume by Region (2027-2032) Table 49. Global Hemostat Powder Sales by Region (2027-2032) & (US$ Million) Table 50. Global Hemostat Powder Sales Market Share in Value by Region (2027-2032) Table 51. Global Hemostat Powder Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Hemostat Powder Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 54. Global Hemostat Powder Sales Market Share in Volume by Application (2021-2026) Table 55. Global Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 56. Global Hemostat Powder Sales Market Share in Value by Application (2021-2026) Table 57. Global Hemostat Powder Price by Application (2021-2026) & (USD/Unit) Table 58. Global Hemostat Powder Sales by Application (2027-2032) & (K Units) Table 59. Global Hemostat Powder Sales Market Share in Volume by Application (2027-2032) Table 60. Global Hemostat Powder Sales by Application (2027-2032) & (US$ Million) Table 61. Global Hemostat Powder Sales Market Share in Value by Application (2027-2032) Table 62. Global Hemostat Powder Price by Application (2027-2032) & (USD/Unit) Table 63. North America Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 64. North America Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 66. Europe Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 70. Latin America Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Hemostat Powder Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Hemostat Powder Sales by Application (2021-2026) & (US$ Million) Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Hemostat Powder Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. C. R. Bard Company Information Table 79. C. R. Bard Business Overview Table 80. C. R. Bard Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. C. R. Bard Hemostat Powder Product Portfolio Table 82. C. R. Bard Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Hemostat Powder Product Portfolio Table 87. Pfizer Recent Development Table 88. CSL Behring Company Information Table 89. CSL Behring Business Overview Table 90. CSL Behring Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. CSL Behring Hemostat Powder Product Portfolio Table 92. CSL Behring Recent Development Table 93. Gelita Medical Company Information Table 94. Gelita Medical Business Overview Table 95. Gelita Medical Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Gelita Medical Hemostat Powder Product Portfolio Table 97. Gelita Medical Recent Development Table 98. Ferrosan Medical Devices Company Information Table 99. Ferrosan Medical Devices Business Overview Table 100. Ferrosan Medical Devices Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Ferrosan Medical Devices Hemostat Powder Product Portfolio Table 102. Ferrosan Medical Devices Recent Development Table 103. Baxter Company Information Table 104. Baxter Business Overview Table 105. Baxter Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Baxter Hemostat Powder Product Portfolio Table 107. Baxter Recent Development Table 108. Celox Company Information Table 109. Celox Business Overview Table 110. Celox Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Celox Hemostat Powder Product Portfolio Table 112. Celox Recent Development Table 113. Equimedical Company Information Table 114. Equimedical Business Overview Table 115. Equimedical Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Equimedical Hemostat Powder Product Portfolio Table 117. Equimedical Recent Development Table 118. Medira Company Information Table 119. Medira Business Overview Table 120. Medira Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Medira Hemostat Powder Product Portfolio Table 122. Medira Recent Development Table 123. Biocer Company Information Table 124. Biocer Business Overview Table 125. Biocer Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Biocer Hemostat Powder Product Portfolio Table 127. Biocer Recent Development Table 128. Hemostasis Company Information Table 129. Hemostasis Business Overview Table 130. Hemostasis Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Hemostasis Hemostat Powder Product Portfolio Table 132. Hemostasis Recent Development Table 133. MBP Company Information Table 134. MBP Business Overview Table 135. MBP Hemostat Powder Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. MBP Hemostat Powder Product Portfolio Table 137. MBP Recent Development Table 138. North America Hemostat Powder Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. North America Hemostat Powder Sales by Country (2021-2026) & (K Units) Table 140. North America Hemostat Powder Sales Market Share by Country (2021-2026) Table 141. North America Hemostat Powder Sales Forecast by Country (2027-2032) & (K Units) Table 142. North America Hemostat Powder Sales Market Share Forecast by Country (2027-2032) Table 143. North America Hemostat Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Hemostat Powder Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Hemostat Powder Market Share by Country (2021-2026) Table 146. North America Hemostat Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Hemostat Powder Market Share Forecast by Country (2027-2032) Table 148. Europe Hemostat Powder Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Europe Hemostat Powder Sales by Country (2021-2026) & (K Units) Table 150. Europe Hemostat Powder Sales Market Share by Country (2021-2026) Table 151. Europe Hemostat Powder Sales Forecast by Country (2027-2032) & (K Units) Table 152. Europe Hemostat Powder Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Hemostat Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Hemostat Powder Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Hemostat Powder Market Share by Country (2021-2026) Table 156. Europe Hemostat Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Hemostat Powder Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Hemostat Powder Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Hemostat Powder Sales by Country (2021-2026) & (K Units) Table 160. Asia-Pacific Hemostat Powder Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Hemostat Powder Sales Forecast by Country (2027-2032) & (K Units) Table 162. Asia-Pacific Hemostat Powder Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Hemostat Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Hemostat Powder Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Hemostat Powder Market Share by Country (2021-2026) Table 166. Asia-Pacific Hemostat Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Hemostat Powder Market Share Forecast by Country (2027-2032) Table 168. Latin America Hemostat Powder Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Latin America Hemostat Powder Sales by Country (2021-2026) & (K Units) Table 170. Latin America Hemostat Powder Sales Market Share by Country (2021-2026) Table 171. Latin America Hemostat Powder Sales Forecast by Country (2027-2032) & (K Units) Table 172. Latin America Hemostat Powder Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Hemostat Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Hemostat Powder Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Hemostat Powder Market Share by Country (2021-2026) Table 176. Latin America Hemostat Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Hemostat Powder Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Hemostat Powder Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Hemostat Powder Sales by Country (2021-2026) & (K Units) Table 180. Middle East and Africa Hemostat Powder Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Hemostat Powder Sales Forecast by Country (2027-2032) & (K Units) Table 182. Middle East and Africa Hemostat Powder Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Hemostat Powder Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Hemostat Powder Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Hemostat Powder Market Share by Country (2021-2026) Table 186. Middle East and Africa Hemostat Powder Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Hemostat Powder Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Hemostat Powder Distributors List Table 191. Hemostat Powder Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Hemostat Powder Image Figure 2. Global Hemostat Powder Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostat Powder Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostat Powder Sales (2021-2032) & (K Units) Figure 5. Gelatin Image Figure 6. Global Gelatin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Fibrin Image Figure 8. Global Fibrin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Cellulose Image Figure 10. Global Cellulose Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Hemostat Powder Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Hemostat Powder Market Share by Type 2025 VS 2032 Figure 15. North America Hemostat Powder Sales Market Share in Volume by Type in 2025 Figure 16. North America Hemostat Powder Sales Market Share in Value by Type in 2025 Figure 17. Europe Hemostat Powder Sales Market Share in Volume by Type in 2025 Figure 18. Europe Hemostat Powder Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Hemostat Powder Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Hemostat Powder Sales Market Share in Value by Type in 2025 Figure 21. Latin America Hemostat Powder Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Hemostat Powder Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Hemostat Powder Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Hemostat Powder Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Hemostat Powder Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Surgical Wound Care Image Figure 28. Global Surgical Wound Care Sales YoY Growth (2021-2032) & (K Units) Figure 29. General Wound Care Image Figure 30. Global General Wound Care Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Hemostat Powder Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Hemostat Powder Market Share by Application 2025 VS 2032 Figure 33. North America Hemostat Powder Sales Market Share in Volume by Application in 2025 Figure 34. North America Hemostat Powder Sales Market Share in Value by Application in 2025 Figure 35. Europe Hemostat Powder Sales Market Share in Volume by Application in 2025 Figure 36. Europe Hemostat Powder Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Hemostat Powder Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Hemostat Powder Sales Market Share in Value by Application in 2025 Figure 39. Latin America Hemostat Powder Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Hemostat Powder Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Hemostat Powder Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Hemostat Powder Sales Market Share in Value by Application in 2025 Figure 43. North America Hemostat Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Hemostat Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Hemostat Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hemostat Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Hemostat Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Hemostat Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hemostat Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Hemostat Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Hemostat Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hemostat Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Hemostat Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Hemostat Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hemostat Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Hemostat Powder Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Hemostat Powder Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Hemostat Powder Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Hemostat Powder Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gelatin
  • Fibrin
  • Cellulose
  • Others
Applications
  • Surgical Wound Care
  • General Wound Care
Companies covered
  • Johnson & Johnson
  • C. R. Bard
  • Pfizer
  • CSL Behring
  • Gelita Medical
  • Ferrosan Medical Devices
  • Baxter
  • Celox
  • Equimedical
  • Medira
  • Biocer
  • Hemostasis
  • MBP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostat Powder Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemostat Powder Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemostat Powder Market by Type
  6. 1.3.1 Gelatin
  7. 1.3.2 Fibrin
  8. 1.3.3 Cellulose
  9. 1.3.4 Others
  10. 1.4 Global Hemostat Powder Market Size by Type
  11. 1.4.1 Global Hemostat Powder Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Hemostat Powder Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Hemostat Powder Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Hemostat Powder Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Hemostat Powder Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Hemostat Powder Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Hemostat Powder Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Hemostat Powder Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemostat Powder Industry Trends
  2. 2.2 Hemostat Powder Industry Drivers
  3. 2.3 Hemostat Powder Industry Opportunities and Challenges
  4. 2.4 Hemostat Powder Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemostat Powder Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemostat Powder Sales (2021-2026)
  3. 3.3 Global Top Players by Hemostat Powder Price (2021-2026)
  4. 3.4 Global Hemostat Powder Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostat Powder Major Company Production Sites & Headquarters
  6. 3.6 Global Hemostat Powder Company, Product Type & Application
  7. 3.7 Global Hemostat Powder Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostat Powder Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostat Powder Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostat Powder Tier 1, Tier 2, and Tier 3
4 Hemostat Powder Regional Status and Outlook
  1. 4.1 Global Hemostat Powder Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemostat Powder Historic Market Size by Region
  3. 4.2.1 Global Hemostat Powder Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemostat Powder Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemostat Powder Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemostat Powder Forecasted Market Size by Region
  7. 4.3.1 Global Hemostat Powder Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemostat Powder Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemostat Powder Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostat Powder by Application
  1. 5.1 Hemostat Powder Market by Application
  2. 5.1.1 Surgical Wound Care
  3. 5.1.2 General Wound Care
  4. 5.2 Global Hemostat Powder Market Size by Application
  5. 5.2.1 Global Hemostat Powder Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hemostat Powder Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hemostat Powder Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hemostat Powder Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hemostat Powder Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hemostat Powder Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hemostat Powder Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hemostat Powder Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Hemostat Powder Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 C. R. Bard
  8. 6.2.1 C. R. Bard Company Information
  9. 6.2.2 C. R. Bard Business Overview
  10. 6.2.3 C. R. Bard Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 C. R. Bard Hemostat Powder Product Portfolio
  12. 6.2.5 C. R. Bard Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Hemostat Powder Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 CSL Behring
  20. 6.4.1 CSL Behring Company Information
  21. 6.4.2 CSL Behring Business Overview
  22. 6.4.3 CSL Behring Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CSL Behring Hemostat Powder Product Portfolio
  24. 6.4.5 CSL Behring Recent Developments
  25. 6.5 Gelita Medical
  26. 6.5.1 Gelita Medical Company Information
  27. 6.5.2 Gelita Medical Business Overview
  28. 6.5.3 Gelita Medical Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Gelita Medical Hemostat Powder Product Portfolio
  30. 6.5.5 Gelita Medical Recent Developments
  31. 6.6 Ferrosan Medical Devices
  32. 6.6.1 Ferrosan Medical Devices Company Information
  33. 6.6.2 Ferrosan Medical Devices Business Overview
  34. 6.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ferrosan Medical Devices Hemostat Powder Product Portfolio
  36. 6.6.5 Ferrosan Medical Devices Recent Developments
  37. 6.7 Baxter
  38. 6.7.1 Baxter Company Information
  39. 6.7.2 Baxter Business Overview
  40. 6.7.3 Baxter Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Baxter Hemostat Powder Product Portfolio
  42. 6.7.5 Baxter Recent Developments
  43. 6.8 Celox
  44. 6.8.1 Celox Company Information
  45. 6.8.2 Celox Business Overview
  46. 6.8.3 Celox Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Celox Hemostat Powder Product Portfolio
  48. 6.8.5 Celox Recent Developments
  49. 6.9 Equimedical
  50. 6.9.1 Equimedical Company Information
  51. 6.9.2 Equimedical Business Overview
  52. 6.9.3 Equimedical Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Equimedical Hemostat Powder Product Portfolio
  54. 6.9.5 Equimedical Recent Developments
  55. 6.10 Medira
  56. 6.10.1 Medira Company Information
  57. 6.10.2 Medira Business Overview
  58. 6.10.3 Medira Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medira Hemostat Powder Product Portfolio
  60. 6.10.5 Medira Recent Developments
  61. 6.11 Biocer
  62. 6.11.1 Biocer Company Information
  63. 6.11.2 Biocer Business Overview
  64. 6.11.3 Biocer Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biocer Hemostat Powder Product Portfolio
  66. 6.11.5 Biocer Recent Developments
  67. 6.12 Hemostasis
  68. 6.12.1 Hemostasis Company Information
  69. 6.12.2 Hemostasis Business Overview
  70. 6.12.3 Hemostasis Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hemostasis Hemostat Powder Product Portfolio
  72. 6.12.5 Hemostasis Recent Developments
  73. 6.13 MBP
  74. 6.13.1 MBP Company Information
  75. 6.13.2 MBP Business Overview
  76. 6.13.3 MBP Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 MBP Hemostat Powder Product Portfolio
  78. 6.13.5 MBP Recent Developments
7 North America by Country
  1. 7.1 North America Hemostat Powder Sales by Country
  2. 7.1.1 North America Hemostat Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemostat Powder Sales by Country (2021-2026)
  4. 7.1.3 North America Hemostat Powder Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemostat Powder Market Size by Country
  6. 7.2.1 North America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemostat Powder Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemostat Powder Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemostat Powder Sales by Country
  2. 8.1.1 Europe Hemostat Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemostat Powder Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemostat Powder Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemostat Powder Market Size by Country
  6. 8.2.1 Europe Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemostat Powder Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemostat Powder Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemostat Powder Sales by Country
  2. 9.1.1 Asia-Pacific Hemostat Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemostat Powder Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemostat Powder Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemostat Powder Market Size by Country
  6. 9.2.1 Asia-Pacific Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemostat Powder Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemostat Powder Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemostat Powder Sales by Country
  2. 10.1.1 South America Hemostat Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemostat Powder Sales by Country (2021-2026)
  4. 10.1.3 South America Hemostat Powder Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemostat Powder Market Size by Country
  6. 10.2.1 South America Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemostat Powder Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemostat Powder Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemostat Powder Sales by Country
  2. 11.1.1 Middle East and Africa Hemostat Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemostat Powder Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemostat Powder Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemostat Powder Market Size by Country
  6. 11.2.1 Middle East and Africa Hemostat Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemostat Powder Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemostat Powder Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemostat Powder Value Chain Analysis
  2. 12.1.1 Hemostat Powder Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemostat Powder Production Mode & Process
  7. 12.2 Hemostat Powder Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemostat Powder Distributors
  10. 12.2.3 Hemostat Powder Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research